Press release
Spinal Cord Stimulators Market to Register a CAGR of 9.83% by 2032, Driven by Rising Chronic Pain Cases and Advancements in Neuromodulation Technologies | DelveInsight
Spinal Cord Stimulators Market
Innovative technologies, including closed-loop stimulation, high-frequency and burst stimulation, and MRI-compatible devices, are driving wider adoption and expanding clinical applications. In addition, rising awareness among healthcare providers, favorable reimbursement scenarios, and the shift toward outpatient implantation procedures are expected to support market expansion through 2032.
DelveInsight's Spinal Cord Stimulators - Market Insight, Competitive Landscape, and Market Forecast - 2032 report delivers comprehensive current and forecast market analysis, leading company market shares, key market drivers, barriers, technology trends, and detailed profiles of prominent players shaping the competitive landscape.
Explore the latest trends and growth drivers in the Spinal Cord Stimulators Market-download your sample report now https://www.delveinsight.com/report-store/spinal-cord-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Spinal Cord Stimulators Market Report
• The global Spinal Cord Stimulators market is projected to experience significant growth, expanding at a CAGR of 9.83%, and reaching a substantial value by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global Spinal Cord Stimulators market during the forecast period.
• Notable Spinal Cord Stimulators companies such as Boston Scientific Corporation, Medtronic, Abbott, Nevro Corp, Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and several others are currently operating in the Spinal Cord Stimulators market.
• In May 2025, University of Minnesota researchers developed a new programming approach for spinal cord stimulators to enhance personalized pain management by filtering out background noise.
• In January 2025, Saluda Medical received FDA approval for its biomarker-based automated patient programming platform, Eva, compatible with Evoke spinal cord stimulator systems.
• In November 2024, Nevro announced that it secured the CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.
• In September 2024, Nevro Corp., a global medical device company focused on transformative solutions for chronic pain, announced U.S. Food and Drug Administration (FDA) approval and the limited market release of HFX iQTM with HFX AdaptivAITM, a personalized, responsive pain management platform that drives the HFX iQ spinal cord stimulation (SCS) system.
To read more about the latest highlights related to the Spinal Cord Stimulators market, get a snapshot of the key highlights entailed in the global Spinal Cord Stimulators market report here https://www.delveinsight.com/report-store/spinal-cord-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Spinal Cord Stimulators Overview
Spinal cord stimulators (SCS) are implantable medical devices designed to manage chronic pain by delivering electrical impulses to the spinal cord, which interfere with pain signal transmission to the brain. Primarily used for patients with conditions such as failed back surgery syndrome, complex regional pain syndrome, and neuropathic pain, SCS offers a minimally invasive alternative to long-term opioid use and other pain management strategies. The device consists of leads placed near the spinal cord and a pulse generator implanted under the skin, which can be externally programmed to adjust stimulation levels based on patient needs.
The market for spinal cord stimulators is expanding rapidly due to the growing prevalence of chronic pain disorders worldwide, increasing awareness of non-opioid pain management options, and advancements in device technology such as rechargeable batteries, MRI-compatible systems, and improved lead designs. Additionally, integration with wireless and remote programming features enhances patient comfort and treatment personalization. Rising healthcare expenditure and an aging global population further contribute to increased adoption, positioning spinal cord stimulators as a key segment in the broader neurostimulation market.
Spinal Cord Stimulators Market Insights
North America is expected to dominate the spinal cord stimulators market in 2024, driven by a rising prevalence of chronic pain and strong demand for advanced pain management solutions. According to the CDC (2023), 51.6 million U.S. adults suffer from chronic pain, including 17.1 million with high-impact chronic pain, while Canada has 8 million individuals living with chronic pain, underscoring the significant regional need for effective therapies. Government initiatives, such as public awareness campaigns during Pain Awareness Month and programs led by the NIH, are increasing education and early intervention efforts, further supporting market growth.
The presence of major industry players and continuous innovation, exemplified by Saluda Medical's 2022 U.S. launch of the Evoke® System-the first SmartSCSTM device-along with favorable reimbursement policies, are enhancing patient access and adoption. Collectively, these factors create a strong foundation for sustained growth of the spinal cord stimulators market in North America from 2025 to 2032.
To know more about why North America is leading the market growth in the Spinal Cord Stimulators market, get a snapshot of the Spinal Cord Stimulators market outlook here https://www.delveinsight.com/report-store/spinal-cord-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Spinal Cord Stimulators Market Dynamics
The growing global burden of chronic pain is driving the demand for spinal cord stimulators as effective pain management solutions. According to the WHO (2023), lower back pain affects 619 million people worldwide, with projections reaching 843 million by 2050. The European Pain Federation (2023) reports that 740 million people experience severe pain at some point in their lives, with 20% suffering from chronic pain lasting over three months. Spinal cord stimulators provide a minimally invasive, drug-free method to block pain signals before they reach the brain, making them a preferred option amid this rising patient population.
Additionally, failed back surgery syndrome (FBSS), affecting 10 to 40% of post-surgical patients, is increasing due to more spinal surgeries for conditions like herniated discs and stenosis; SCS offers an effective alternative when repeated surgeries fail to alleviate pain. Innovation also fuels market growth, exemplified by Abbott Laboratories' FDA-approved Eterna system in 2022, the smallest rechargeable implantable spinal cord stimulator for chronic pain. Despite these positive drivers, challenges such as high procedure costs and potential device-related complications may restrain market expansion through 2032.
Get a sneak peek at the Spinal Cord Stimulators market dynamics @ https://www.delveinsight.com/report-store/spinal-cord-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Spinal Cord Stimulators Market CAGR: ~9.83%
Key Spinal Cord Stimulators Companies: Boston Scientific Corporation, Medtronic, Abbott, Nevro Corp, Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and others.
Spinal Cord Stimulators Market Segmentation
Market Segmentation By Product Type: Rechargeable, Non-Rechargeable, and others.
Market Segmentation By Application: Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), and others.
Market Segmentation By End-User: Hospitals, Clinics, and Ambulatory Surgical Centers.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the Spinal Cord Stimulators market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/spinal-cord-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Spinal Cord Stimulators Market Report Introduction
2. Spinal Cord Stimulators Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Spinal Cord Stimulators Market Key Factors Analysis
6. Spinal Cord Stimulators Market Porter's Five Forces Analysis
7. Spinal Cord Stimulators Market Layout
8. Spinal Cord Stimulators Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us
Jatin Vimal
jvimal@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Cord Stimulators Market to Register a CAGR of 9.83% by 2032, Driven by Rising Chronic Pain Cases and Advancements in Neuromodulation Technologies | DelveInsight here
News-ID: 4166985 • Views: …
More Releases from DelveInsight
Transradial Access Products Market to Register a CAGR of 7.20% by 2032, Driven b …
The transradial access products market is expected to experience steady growth, fueled by the increasing adoption of transradial access in coronary angiography and percutaneous coronary interventions due to lower complication rates, faster recovery, and improved patient comfort compared to transfemoral approaches. Advancements in radial sheaths, catheters, and hemostasis devices are enhancing procedural safety and success rates, further supporting clinical preference for the radial route. In addition, the growing global cardiovascular…
Spinal Fusion Devices Market to Register a CAGR of 5.31% by 2032, Driven by Risi …
The spinal fusion devices market is expected to witness robust growth, fueled by the increasing prevalence of degenerative spinal disorders, trauma cases, and the growing aging population worldwide. Advancements in minimally invasive spine surgery, the development of motion-preserving technologies, and the adoption of biocompatible materials are significantly improving patient outcomes and reducing recovery times.
Furthermore, the integration of navigation systems, robotics, and 3D printing is enhancing surgical precision and implant…
Nuclear Imaging Equipment Market to Register a CAGR of 4.96% by 2032, Driven by …
The nuclear imaging equipment market is poised for substantial growth, fueled by the increasing prevalence of cancer and cardiovascular diseases, the growing demand for precision diagnostics, and advancements in hybrid imaging technologies such as PET/CT, PET/MRI, and SPECT/CT. Digital innovations, including time-of-flight PET and CZT-based detectors, are improving image resolution, scan speed, and quantitative accuracy, enhancing both clinical outcomes and patient experience.
Additionally, the adoption of AI-enabled imaging workflows, automation,…
Surgical Energy Generators Market to Register a CAGR of 3.37% by 2032, Driven by …
The surgical energy generators market is set to witness steady growth, driven by the rising adoption of minimally invasive and laparoscopic procedures, increasing demand for precision-based surgical tools, and advancements in energy-based technologies. Innovations in electrosurgical, ultrasonic, and hybrid energy platforms are enhancing safety, efficiency, and clinical outcomes across specialties such as general surgery, gynecology, urology, and oncology. The integration of smart energy systems with real-time feedback, improved tissue selectivity,…
More Releases for Spinal
Evolving Market Trends In The Spinal Fusion Devices Industry: Advancements In Sp …
The Spinal Fusion Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
What Is the Expected Spinal Fusion Devices Market Size During the Forecast Period?_x000D_
Over the past few years, there has been a significant growth in the spinal fusion devices market. The market is projected…
Key Influencer in the Spinal Fusion Devices Market 2025: Rising Spinal Disorder …
What Is the Forecasted Market Size and Growth Rate for the Spinal Fusion Devices Market?
The market for spinal fusion devices has experienced significant growth in the past couple of years. Expectations are that it will rise from estimates of $7.85 billion in 2024 to approximately $8.31 billion in 2025, giving us a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this notable expansion during the historical period can…
Disposable Spinal Instrument Market: Revolutionizing Spinal Surgery with Hygiene …
Introduction
The medical device market has witnessed a surge in demand for disposable instruments, especially in areas where hygiene, precision, and efficiency are paramount. One such sector experiencing rapid growth is the disposable spinal instrument market. Spinal surgeries, being intricate and requiring high precision, have traditionally relied on reusable instruments. However, growing concerns about hygiene, infection control, and surgical efficiency have accelerated the shift toward disposable spinal instruments. These devices not…
Endoscopic Spinal Surgery Market: Minimally Invasive Solutions for Spinal Disord …
Global Endoscopic Spinal Surgery Market size was valued at US$ 667 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 7.9% through 2022 to 2029, reaching nearly US$ 1137 Mn.
Endoscopic Spinal Surgery Market Overview:
Maximize Market Research is a research firm that has published a detailed analysis of the "Endoscopic Spinal Surgery Market". MMR in-depth market assessments in research reports consider significant technological advancements in…
Spinal Resilience: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
Market Outlook:
Charting Progress: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
The Acute Spinal Cord Injury Drug Pipeline Landscape sets its sights on a decade of advancements poised to redefine the trajectory of spinal resilience. This comprehensive outlook explores the unfolding strategies, innovations, and breakthroughs that promise to revolutionize the landscape of acute spinal cord injury treatment.
Market Drivers:
Neuroregeneration on the Horizon: At the forefront of the Acute Spinal Cord Injury Drug…
Spinal Laminoplasty Market - Revolutionizing spinal care with minimally invasive …
Newark, New Castle, USA: The "Spinal Laminoplasty Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Spinal Laminoplasty Market: https://www.growthplusreports.com/report/spinal-laminoplasty-market/8601
This latest report researches the industry structure, sales, revenue,…
